– Annamycin continues to demonstrate no evidence of cardiotoxicity to date, now in a total of 62 subjects across three of the Company's Annamycin clinical trials
Read more at prnewswire.comMoleculin Announces New Positive Independent Report of No Cardiotoxicity in Annamycin
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here